Document Detail

Structure based design of 11β-HSD1 inhibitors.
MedLine Citation:
PMID:  20809895     Owner:  NLM     Status:  In-Process    
Controlling elevated tissue-specific levels of cortisol may provide a novel therapeutic approach for treating metabolic syndrome. This concept has spurred large scale medicinal chemistry efforts in the pharmaceutical industry for the design of 11β-HSD1 inhibitors. High resolution X-ray crystal structures of inhibitors in complex with the enzyme have facilitated the structure-based design of diverse classes of molecules. A summary of binding modes, trends in structure-activity relationships, and the pharmacodynamic data of inhibitors from each class is presented.
Suresh Singh; Colin Tice
Related Documents :
16341125 - Small molecule inhibitors of apaf-1-related caspase- 3/-9 activation that control mitoc...
15182805 - Selecting compounds for focused screening using linear discriminant analysis and artifi...
11913725 - Site-specific molecular design and its relevance to pharmacogenomics and chemical biology.
16472225 - Reverse pharmacognosy: application of selnergy, a new tool for lead discovery. the exam...
23889525 - Discovery of new inhibitors of mycobacterium tuberculosis inha enzyme using virtual scr...
19836345 - Crystal structure of the de-ubiquitinating enzyme uch37 (human uch-l5) catalytic domain.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current pharmaceutical biotechnology     Volume:  11     ISSN:  1873-4316     ISO Abbreviation:  Curr Pharm Biotechnol     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100960530     Medline TA:  Curr Pharm Biotechnol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  779-91     Citation Subset:  IM    
Vitae Pharmaceuticals, 502 W. Office Center Drive, Fort Washington, PA 19034, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Application of NMR spectroscopy in medicinal chemistry and drug discovery.
Next Document:  Open access high throughput drug discovery in the public domain: a Mount Everest in the making.